Smart & BiggarPartner, Toronto; Barrister and Solicitor; Patent and Trademark Agent

Nancy P. Pei

About Nancy P. Pei

Nancy P. Pei is a lawyer practicing pharmaceutical, litigation, chemical & industrial biotechnology and 3 other areas of law. Nancy P. received a B.Sc. degree from University of Toronto in 1991, and has been licensed for 29 years. Nancy P. practices at Smart & Biggar in Toronto, ON.

Reviews for Nancy P.

This lawyer does not have any client reviews on Lawyers.com yet

Write a Review

Services

Areas of Law

  • Litigation
  • Other 5
    • Pharmaceutical
    • Chemical & Industrial Biotechnology
    • Life Sciences
    • Pharmaceutical Regulatory & Compliance
    • Cleantech

Practice Details

  • Firm Information
    Position
    Partner, Toronto; Barrister and Solicitor; Patent and Trademark Agent
    Firm Name
    Smart & Biggar
  • Representative Cases & Transactions
    Cases
    Experience: Selected Cases: AstraZeneca v Apotex Inc, 2017 FC 726.
    AstraZeneca Canada Inc v Apotex Inc, 2015 FC 322, aff'd in part 2017 FCA 9, SCC leave denied
    Photocure ASA v Canada ( Health ), 2015 FC 959
    Apotex Inc v AstraZeneca Canada Inc, 2012 FC 559, aff'd 2013 FCA 77
    Bayer Inc v Canada ( Health ), 2009 FC 1171, aff'd 2010 FCA 161, leave to appeal denied
    Apotex Inc v Canada ( Health ), 2009 FC 721
    Apotex Inc v Syntex Pharmaceuticals International Limited, 2009 FC 494, aff'd 2010 FCA 155
    Apotex Inc v AstraZeneca Canada Inc , 2009 FC 120
    Immunex Corporation v Canada ( Health ), 2008 FC 1409
    Sanofi-Aventis Canada Inc v Canada ( Health ), 2008 FC 1062, aff'd 2009 FCA 169
    Bayer Inc v Canada ( Health ), 2008 FC 857, aff'd 2009 FCA 133
    Sanofi-Aventis Canada Inc v Canada ( Health ),2007 FC 1156, rev'd 2008 FC 129
    Ferring Inc v Canada ( Health ), 2007 FC 300, aff'd 2007 FCA 276
    Apotex Inc v Sanofi-Aventis Canada Inc , 2007 FCA 7
    Apotex Inc v Merck & Co Inc , 2006 FCA 198
    Merck & Co Inc v Apotex Inc, 2006 FC 524, aff'd 2006 FCA 323
    Merck & Co Inc v Apotex Inc, 2005 FC 1560
    Apotex Inc v Syntex Pharmaceuticals International Ltd, 2005 FC 1310, aff'd 2006 FCA 60
    Merck & Co Inc v Apotex Inc , 2005 FC 1251
    AstraZeneca Canada Inc v Canada ( Minister of Health ), 2005 FCA 189, rev'd [2006] 2 SCR 560
    AstraZeneca Canada Inc v Canada ( Minister of Health ), 2005 FCA175, aff'g 2004 FC 736
    AstraZeneca Canada Inc v Canada ( Minister of Health ), 2005 FCA 58, aff'g 2004 FC 1278
    Apotex Inc v Syntex Pharmaceuticals International Ltd, 2005 FC 121, aff'd 2005 FC 480, aff'd 2005 FCA 424
    Hoffman-La Roche Ltd v Canada ( Minister of Health ), 2004 FC 1547, aff'd 2005 FCA 140
    AstraZeneca Canada Inc v Apotex Inc, 2004 FC 1075, aff'd 2005 FCA 216, leave to appeal to appeal denied
    AB Hassle v Genpharm Inc, 2004 FC 892, aff'd 2004 FCA 413, leave to appeal denied
    Apotex Inc v Syntex Pharmaceuticals International Ltd, 2004 FC 383
    Merck & Co Inc v Apotex Inc, 2003 FCA 488, rev'g in part 2003 FCT 159, aff'g 2002 FCT 509
    Apotex Inc v Merck & Co, 2003 FCA 438, rev'g 2003 FCT 160
    Novopharm Ltd v AstraZeneca AB, 2003 FC 1212
    AstraZeneca AB v Novopharm Ltd, 2003 FCA 57, aff'g 2001 FCT 1171
    Glaxo Group Limited v Canada ( Minister of National Health
    Welfare ), 1997 CanLII 5591

Experience

  • Bar Admission & Memberships
    Admissions
    1997, Ontario
    1998, Registered Trade-mark Agent
    2004, Registered Patent Agent
    Memberships

    Professional Involvement

    Memberships
    •fellow, Intellectual Property Institute of Canada

    Bar Fellowship
    Intellectual Property Institute of Canada

    Speaking engagements

    •Patenting Drugs in Canada: Differences and Dividing Lines North and South of the Border, Fifth Annual RIPL Symposium, The John Marshall Law School, Chicago, IL, November 2013
    •Supreme Court of Canada PLAVIX Decision: The Aftermath, panel discussion at the Drug Patent and Legal Forum, Toronto, May 2009
    •Selecting the Right Expert, Advocacy Before the Federal Court in Intellectual Property Matters - Expert Witnesses, Canadian Bar Association, Ottawa, May 2008
    •The AstraZeneca Decision of the Supreme Court of Canada - Downstream Effects, Drug Patents and Legal Forum, Insight Information, Toronto, February 2008
    •Patent Time Lines: Maximizing Possibilities from Both Perspectives (co-presenter: Angela Furlanetto, Dimock Stratton LLP), 6th Annual Forum on Pharma Patents, Canadian Institute, Toronto, October 2007
    •Changes toPatented Medicines (NOC) Regulations- Industry Perspective (co-presenter: Gunars A. Gaikis), From Product Monograph to Promotion and Other Emerging Initiatives, Canadian Association of Professional Regulatory Affairs, Toronto, November 2007
    •Maintaining Profitability while Minimizing the Impact of Patent Expiry and Generic Entry, Drug Pricing & Reimbursement in Canada Conference, Canadian Institute, Toronto, June 2007
    •Developing and Managing Your Patent Portfolio - Maximizing Patent Life Cycles and Minimizing the Impact of Patent Expiry and Innovation Uncertainty (co-presenter: Yoon Kang), 5th Annual Forum on Pharma Patents, Canadian Institute, Toronto, October 2006

  • Education & Certifications
    Law School
    University of Toronto
    Class of 1995
    LL.B.
    Other Education
    University of Toronto
    Class of 1991
    B.Sc.
    Pharmacy
Case type is required.
I am is required.
First name is required.
Last name is required.
A valid zip code is required.
Country is required.
State is required.
A valid city is required.
A valid email address is required.
A valid phone number is required.
Message is required.
0/1000 characters

By clicking the Submit button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Lawyers.com and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.

This site is protected by reCAPTCHA. See Google’s Privacy Policy and Terms of Service.

Thank you! Your message has been successfully sent.

For your records, a copy of this email has been sent to test@test.com.

Summary of Your Message
Case Type:
I am a/an:
First Name:
Last Name:
City:
Zip Code or Postal Code:
State:
Country:
Phone Number:
Message: